Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc.verified

INO

Price:

$5.52

Market Cap:

$143.32M

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, pen...[Read more]

Industry

Biotechnology

IPO Date

1998-12-08

Stock Exchange

NASDAQ

Ticker

INO

The Enterprise Value as of November 2024 (TTM) for Inovio Pharmaceuticals, Inc. (INO) is 121.91M

According to Inovio Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 121.91M. This represents a change of -37.75% compared to the average of 195.83M of the last 4 quarters.

Inovio Pharmaceuticals, Inc. (INO) Historical Enterprise Value (quarterly & annually)

How has INO Enterprise Value performed in the past?

The mean historical Enterprise Value of Inovio Pharmaceuticals, Inc. over the last ten years is 2.95B. The current 121.91M Enterprise Value has changed 313.37% with respect to the historical average. Over the past ten years (40 quarters), INO's Enterprise Value was at its highest in in the June 2020 quarter at 50.27B. The Enterprise Value was at its lowest in in the June 2023 quarter at 97.01M.

Quarterly (TTM)
Annual

Average

2.95B

Median

2.60B

Minimum

151.60M

Maximum

6.47B

Inovio Pharmaceuticals, Inc. (INO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Inovio Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 188.08%

Maximum Annual Enterprise Value = 6.47B

Minimum Annual Increase = -90.86%

Minimum Annual Enterprise Value = 151.60M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023151.60M-57.65%
2022358.00M-64.34%
20211.00B-13.54%
20201.16B188.08%
2019403.08M-90.86%
20184.41B9.43%
20174.03B-33.53%
20166.06B11.38%
20155.44B-15.93%
20146.47B1.43%

Inovio Pharmaceuticals, Inc. (INO) Average Enterprise Value

How has INO Enterprise Value performed in the past?

The current Enterprise Value of Inovio Pharmaceuticals, Inc. (INO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

504.51M

5-year avg

615.56M

10-year avg

2.95B

Inovio Pharmaceuticals, Inc. (INO) Enterprise Value vs. Peers

How is INO’s Enterprise Value compared to its peers?

Inovio Pharmaceuticals, Inc.’s Enterprise Value is less than Novavax, Inc. (0), less than Vaxart, Inc. (1.00B), less than Enveric Biosciences, Inc. (144.74M), greater than CohBar, Inc. (636.29K), greater than Ocean Biomedical, Inc. (-4506335.00), greater than Hepion Pharmaceuticals, Inc. (42.20M), greater than Elevation Oncology, Inc. (1.72M), greater than AVROBIO, Inc. (2.36M), greater than null (-85302404.00),

CompanyEnterprise ValueMarket cap
0$1.46B
1.00B$164.89M
144.74M$4.14M
636.29K$1.42M
-4506335.00$31.18M
42.20M$3.68M
1.72M$30.89M
2.36M$5.24M
-85302404.00$0

Build a custom stock screener for Inovio Pharmaceuticals, Inc. (INO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inovio Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Inovio Pharmaceuticals, Inc. (INO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Inovio Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Inovio Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Inovio Pharmaceuticals, Inc. (INO)?

What is the 3-year average Enterprise Value for Inovio Pharmaceuticals, Inc. (INO)?

What is the 5-year average Enterprise Value for Inovio Pharmaceuticals, Inc. (INO)?

How does the current Enterprise Value for Inovio Pharmaceuticals, Inc. (INO) compare to its historical average?